Thus, this novel fusion protein appears to fulfill the prerequisite of target-cell restricted activity and may be a useful agent for the selective enhancement of OX40-mediated T-cell co-stimulation in the tumor micro-environment. This evidence concerns the gene TNFRSF4 and neoplasm.